Phase II OVARIO study of niraparib + bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab
暂无分享,去创建一个
Richard O. Moore | H. Gray | G. Konecny | E. Keeton | T. Krivak | E. Hamilton | D. Richardson | G. Wright | Jian Chen | A. Clements | J. Belotte | M. Hardesty | E. Fleming